Regulatory Affairs Fast Track Pathways for Approval and Launch of COVID Related Therapies

Abstract

Pharmaceutical industry had very responsible job to develop therapies related for COVID-19 related therapies. This responsibility was completed successfully with minimum time for drug approval and review process compared to any other traditional vaccine development plan. This article summarise the challenges Pharmaceutical companies and regulator faced to meet urgent crises in pandemic. It also gives information about the current ongoing major studies for COVID-19.